4th Antigen-Specific Immune Tolerance Drug Development

  • Jan 2022
  • Online Event

Event has no final dates - Instead, you may be interested in:

RSV Drug Development Summit
17-18 Nov 2021
Online Event

Description

The 4th Antigen-Specific Immune Tolerance Drug Development is dedicated to safe and effective antigen-specific immune tolerance therapies.

The 4th Antigen-Specific Immune Tolerance Drug Development covers topics such as:

  • Analyzing the Scope & Strategies to Antigen-Specific Immune Tolerance
  • Dynamics of Underlying Causes & Current Understandings of Autoimmunity
  • Improving the Pre-Clinical Predictability of Antigen-Specific Immune Tolerance Therapies
  • Identification, Validation & Targeting of Specific Antigens for Immune Tolerance Therapies
  • Optimizing Clinical Development & Paving the Future of Antigen-Specific Immune Tolerance Therapies
  • Surging Translational Potentials of Pre-Clinical Antigen-Specific Therapies
  • Commercialization: Future Proofing Immune Tolerance Therapies for Patients

The 4th Antigen-Specific Immune Tolerance Drug Development might be held in Jan 2022.

More Details

Prices:
998-2999 US Dollar (Estimated)
Exhibition:
No exhibition
Organizer:
Hanson Wade
Website:

Future Events

  • 4th Antigen-Specific Immune Tolerance Drug Development - Jan 2022, Online Event (73896)
  • 5th Antigen-Specific Immune Tolerance Drug Development - 2023, (81459)

Past Events

  • 3rd Antigen-Specific Immune Tolerance Drug Development - 25-27 Feb 2020, Colonnade Hotel, Boston, MA, United States (81461)

Important

Please, check the official event website for possible changes, before making any traveling arrangements

Event Categories

Health & Medicine: Healthcare, Immunology, Pharma

Other Events with Similar Categories

Other Events with Similar Location or Organizer

Featured Conferences & Exhibitions